Presentation TCT 2017 How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others) Presenter: Laura Mauri October 30, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 Up Next Presentation TCT 2017 Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others) Presenter: Stuart J. Pocock October 30, 2017 More slides + Presentation TCT 2017 Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice Presenter: Vasilios Papademetriou October 30, 2017 Presentation TCT 2017 New U.S. Hypertension Guidelines and Treatment Targets Presenter: Sandra J Taler October 30, 2017 We Recommend
Presentation TCT 2017 Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others) Presenter: Stuart J. Pocock October 30, 2017
Presentation TCT 2017 Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice Presenter: Vasilios Papademetriou October 30, 2017
Presentation TCT 2017 New U.S. Hypertension Guidelines and Treatment Targets Presenter: Sandra J Taler October 30, 2017